IL15 and ovarian carcinoma: Based on our previous findings [19], we hypothesized that the hyporesponsiveness to IL-2, which we observed in NK cells of certain ascites from women with epithelial ovarian cancer, could be a consequence of impairment of the IL-2 and IL-15 signaling pathways.